Valuation Policy And Fair Value Governance

The following discussion illustrates a project that is well suited to the capabilities of an independent consultant in the Umbrex Private Equity Practice. This is an illustrative example. Umbrex consultants adapt their methodology, timeline, and deliverables to the specific needs of each client.

1) Client Situation

The client operated across multi-product private equity platforms and required support with Valuation Policy And Fair Value Governance in the context of Private Equity. Stakeholders included Mega/Large-Cap Private Equity Buyout Firms coordinating concurrent flagship funds and GP-led continuation vehicles, Mid-Market & Lower Mid-Market Private Equity Sponsors institutionalizing fund finance processes, Growth Equity Investors (Private Equity) scaling with lean teams, Private Equity Operating Partners & Value Creation Teams providing portfolio performance inputs, and PE-Owned Portfolio Companies supplying quarterly data. The diagnostic we conducted surfaced structural issues that impeded quarterly valuation consistency, auditor alignment, and regulator-ready defensibility under ASC 820 and related guidance:

• Policy gaps and inconsistent application
  • ASC 820 concepts (unit of account, exit price notion, market participant assumptions, hierarchy and inputs) were documented at a high level but not operationalized in procedures. Approaches (market, income, and cost) and methods (GPCM, GTM, DCF, PWERM, OPM, hybrid/Monte Carlo) were applied inconsistently across funds and geographies.
• Calibration and backtesting not embedded
  • Transaction-to-valuation calibration to initial recognition was not formalized; subsequent quarter marks drifted without clear link to observable inputs. Backtesting of prior marks to outcomes was ad hoc, limiting continuous improvement and auditor dialogue.
• Level 3 inputs and documentation variability
  • Unobservable inputs (revenue growth, margins, WACC, credit spreads, volatility, control and marketability adjustments) lacked standardized source support and sensitivity analysis. Valuation memos varied in depth, with limited support for discounts/premia, unit of account judgments, and liquidity/marketability considerations.
• Committee and governance cadence undefined
  • No formal Valuation Review Committee (VRC) charter existed; meeting minutes and approval thresholds were not standardized. Reviewer independence and segregation of duties were unclear; change-control over models and inputs was not documented.
• Auditor and independent valuer alignment friction
  • Audit PBC (prepared by client) lists were rebuilt each quarter. Independent valuation firm scopes, materiality thresholds, and role delineation were not codified, creating duplicative requests and surprises late in the close calendar.
• GP-led continuation and secondary processes unlinked
  • Fair value marks used for GP-led continuation pricing and tender processes were not reconciled to policy. Valuation narratives for fairness opinion interactions were built separately from quarterly memos, extending cycle time and scrutiny.
• Control framework incomplete
  • Management assertions and internal control over financial reporting (ICFR)-like controls were not mapped to valuation tasks. Evidence logs, model inventories, and sign-offs were scattered across drives; versioning of key models lacked governance.
• Regulatory and investor transparency at risk
  • ASC 820/fair value hierarchy and ILPA/IPEV-aligned disclosures were inconsistent across funds; inputs, transfers between levels, and sensitivity to significant unobservable inputs were not disclosed uniformly. SEC/OCIE examination readiness was limited by gaps in documentation.
• Underperforming KPIs
  • Late-cycle valuation adjustments, extended auditor queries, rework in independent valuation firm reviews, inconsistent Level 2 vs. Level 3 classifications, elevated variance between preliminary and final marks, and compressed close timelines persisted.

2) Project Objective

The primary objective focused on establishing ASC 820 methodologies, calibration, committees, and documentation standards to improve quarterly valuation consistency, auditor alignment, and regulator-ready defensibility across products and vintages.

Secondary objectives included:

• Codifying a valuation policy and procedures manual that operationalized ASC 820 (and IFRS 13/IPEV where relevant), including unit of account, methodology selection, hierarchy classification, and disclosure standards.
• Implementing a calibration framework at initial recognition and ongoing backtesting to tie marks to observable inputs and realized outcomes.
• Standing up a Valuation Review Committee (VRC) with charter, roles, independence standards, and approval thresholds; embedding meeting cadence, minutes, and issue tracking.
• Standardizing valuation memo templates, model inventories, input sourcing, sensitivity analyses, and change-control.
• Aligning with auditors and independent valuation providers on scope, materiality, and timelines; streamlining PBC and tie-outs.
• Integrating GP-led continuation and secondary pricing mechanics into policy, including fairness opinion-ready narratives and documentation.
• Mapping ICFR-like controls, sign-offs, and evidence trails to valuation tasks; deploying dashboards and close calendars.

3) Methodology and Approach

Workstream 1: Policy Design—ASC 820 Operating Manual

We translated standards into actionable procedures.

• Activities we conducted:
  • Drafted a valuation policy that defined the unit of account (equity, preferred equity, convertibles, debt tranches; whole company vs. partial interests), exit price notion, market participant assumptions, and fair value hierarchy (Level 1–3) classification criteria.
  • Codified methodology selection: market approach (GPCM, GTM), income approach (single/three-statement DCF, in-place cash flow models), cost approach (for early-stage or hard-asset scenarios), and hybrid/option-based models (OPM, PWERM, Monte Carlo) for complex capital structures.
  • Set criteria for adjustments: control premiums, discounts for lack of control (DLOC), discounts for lack of marketability (DLOM), blockage adjustments, non-operating assets/liabilities, and working capital normalizations.
  • Specified evidence requirements and preferred data sources (e.g., Bloomberg/Capital IQ for comps and yields, PitchBook for private transactions, broker quotes, pricing services for debt, third-party appraisal reports) with a sourcing hierarchy.
  • Defined disclosure standards: significant unobservable inputs, sensitivity to key inputs, transfers between levels, valuation techniques, and changes in techniques or assumptions period-over-period.
• Tools/frameworks used: valuation policy manual, methodology decision trees, hierarchy classification guides, disclosure checklist.
• Stakeholders involved: fund finance, controller, legal/compliance, external valuation advisors, audit liaison.

Workstream 2: Calibration and Backtesting Framework

We put transaction-to-valuation linkages and outcome testing on rails.

• Activities we conducted:
  • Established calibration protocols at initial recognition: anchored model outputs to observed transaction terms (price, structure, seniority, warrants), market-implied multiples/yields, and contemporaneous market conditions; documented calibration exhibits and residual adjustments.
  • Built backtesting procedures to compare realized exit values to prior-period marks, attributing variance to model inputs (multiples, growth, margins, discount rates), company performance vs. plan, and exogenous market movements.
  • Implemented feedback loops: flagged recurring bias in input selection; updated policy guardrails; logged auditor/independent valuer feedback for the following cycle.
• Tools/frameworks used: calibration worksheets, backtesting dashboards, input attribution analysis, policy exception log.
• Stakeholders involved: valuation leads, deal teams, operating partners, external valuation firm, auditors.

Workstream 3: Model Library and Input Governance

We standardized models and controlled unobservable inputs.

• Activities we conducted:
  • Curated a model inventory: DCF templates with WACC build-up (risk-free rate, beta, size/industry premia, specific risk), terminal value methods (perpetuity vs. exit multiple), Monte Carlo engines for complex securities, PWERM for binary/outcome-weighted cases, and OPM for stacked capital structures.
  • Defined input governance: approved sources for betas/multiples/yields; peer selection protocols; comp set refresh cadence; WACC and credit spread updates; preferred methods for DLOC/DLOM estimation (e.g., restricted stock studies, protective put models).
  • Embedded sensitivity analyses: tornado charts, one- and two-variable tables, scenario matrices; required documentation of how the mark would change under reasonable alternative assumptions.
  • Implemented version control and change logs; established model custodians; restricted write access and archived prior iterations.
• Tools/frameworks used: model templates, input source catalog, sensitivity toolkit, model inventory and change-control register.
• Stakeholders involved: valuation team, FP&A, IT/data governance, external valuation advisors.

Workstream 4: Quarterly Process, Close Calendar, and VRC

We embedded governance and cadence into the quarter-end.

• Activities we conducted:
  • Authored a quarterly close calendar: data request dates to portfolio companies, cut-off for KPI and financials, preliminary mark review, VRC sessions, auditor/independent firm review windows, and finalization dates.
  • Stood up a Valuation Review Committee with charter, quorum, independence criteria, conflict management (deal team vs. reviewer), and approval thresholds by materiality and hierarchy level.
  • Created VRC meeting templates: agenda, input change summaries, calibration checks, sensitivity highlights, significant judgments (unit of account, hierarchy transfers), and minutes templates with decisions and follow-ups.
  • Mapped segregation of duties: preparer, reviewer, approver roles; instituted attestations and sign-offs.
• Tools/frameworks used: close calendar, VRC charter and agenda/minutes templates, RACI matrix, attestation forms.
• Stakeholders involved: CFO, valuation lead, deal teams, compliance, auditors/independent valuation firm (observer where appropriate).

Workstream 5: Memo and Documentation Standards

We standardized the written record behind every mark.

• Activities we conducted:
  • Developed memo templates for equity and debt: company overview, recent events, performance vs. plan, methodology rationale, comp sets and adjustments, DCF/PWERM/OPM outputs, calibration narrative, significant unobservable inputs with ranges, sensitivity analyses, and conclusion.
  • Included hierarchy classification determination; unit of account rationale; description of market participant assumptions; and linkage to audit disclosures.
  • Embedded citation boxes for data sources; appended model change logs; attached management representations from portfolio companies; and included backtesting exhibits when applicable.
• Tools/frameworks used: valuation memo templates, source citation checklist, representation letter templates, backtesting appendix.
• Stakeholders involved: valuation preparers, deal teams, operating partners, controller, auditors.

Workstream 6: Auditor and Independent Valuer Alignment

We aligned expectations and smoothed the close.

• Activities we conducted:
  • Conducted pre-clear meetings with audit teams to confirm policy interpretations (e.g., calibration approach, DLOM estimation method, hierarchy transfers, continuation vehicle treatment) and PBC timelines.
  • Defined independent valuation firm scope (coverage %, rotation, materiality), deliverables (valuation reports, model reviews), tie-out checkpoints, and communication protocols.
  • Compiled a standing PBC list with cross-references to memos and models; built a tie-out deck summarizing quarter-over-quarter changes and significant judgments.
• Tools/frameworks used: audit alignment memos, independent valuer scope of work and calendar, PBC index, tie-out deck.
• Stakeholders involved: audit liaison, auditors, independent valuation firm, valuation team.

Workstream 7: GP-Led Continuation and Secondary Integration

We ensured special transactions aligned with policy and were defensible.

• Activities we conducted:
  • Integrated GP-led continuation vehicle pricing into policy: valuation date conventions, role of third-party price discovery, reconciliation to prior marks, and fairness opinion-ready exhibits.
  • Documented treatment of tender offers/strip sales and investor choice architecture; mapped MFN and side letter effects on economics and disclosures.
  • Prepared communication templates for LPs and advisors, consistent with ASC 820/IPEV expectations.
• Tools/frameworks used: continuation valuation addendum, pricing reconciliation workbook, fairness support package templates.
• Stakeholders involved: deal team, IR, legal, external advisors, auditors.

Workstream 8: Controls, ICFR Mapping, and Evidence Trail

We created a control environment commensurate with investor and regulator expectations.

• Activities we conducted:
  • Mapped valuation tasks to control objectives: completeness and accuracy of inputs, selection and oversight of methods, segregation of duties, review and approval, evidence retention, and change management.
  • Built a control matrix with control owners, frequency, evidence requirements, and deficiency remediation steps; implemented a document repository with access controls and retention schedules.
  • Established quarterly certifications from valuation preparers and approvers; created control testing scripts suitable for internal audit or third-party assessments.
• Tools/frameworks used: valuation control matrix, evidence checklist, certification templates, control testing playbook.
• Stakeholders involved: controller, compliance, internal audit/third-party, valuation team.

Workstream 9: Reporting, Disclosures, and Dashboards

We made valuation transparent internally and externally.

• Activities we conducted:
  • Aligned financial statement disclosures with ASC 820: valuation techniques, inputs, Level 3 roll-forwards, sensitivity to significant unobservable inputs, and transfers between levels; harmonized with ILPA/IPEV expectations where applicable.
  • Built internal dashboards: mark movement by driver (performance vs. market vs. structure), Level 1/2/3 mix, calibration status, backtesting variance, and VRC issues log; connected to close calendar and PBC status.
  • Created board-ready summaries with narratives of material judgments and period-over-period changes.
• Tools/frameworks used: disclosure templates, valuation driver dashboards, board summary templates.
• Stakeholders involved: CFO, controller, IR, valuation leads, board liaisons.

Workstream 10: Training, Handoff, and Continuous Improvement

We ensured adoption and sustainability.

• Activities we conducted:
  • Delivered training on ASC 820 concepts, methodology selection, calibration/backtesting, memo preparation, and controls; hosted workshops for deal teams on providing inputs aligned to market participant assumptions.
  • Handed off a valuation playbook and calendar; defined roles and responsibilities; scheduled quarterly policy refresh and annual methodology benchmarking.
  • Created a feedback loop with auditors and independent valuation providers to inform future policy refinements.
• Tools/frameworks used: training curriculum, valuation playbook, RACI, policy refresh log, benchmark pack.
• Stakeholders involved: valuation and finance teams, deal teams, auditors/independent valuation providers.

4) Data Request

We requested datasets and artifacts required to draft policy, build models, run calibration/backtesting, and support audit-ready documentation. Typical horizons covered inception-to-date history for each portfolio company and the most recent 8–12 quarters of detailed inputs.

• Legal and structural documents:
  • Shareholder agreements, term sheets, cap tables, debt agreements, warrants/derivatives documentation, board minutes (selected for valuation events), key contracts affecting cash flows.
• Portfolio company data:
  • Historical financials and forecasts (revenue, EBITDA, cash flows); KPI dashboards and cohort metrics; budgets and latest reforecasts; management commentary on performance drivers and risks.
• Transaction and market data:
  • Recent company-specific transactions (primary/secondary) with terms; comparable public company lists and trading data; precedent transaction data; sector research; debt pricing (yields, spreads), broker quotes for securities.
• Valuation models and memos (if any):
  • Prior valuation workpapers, DCFs, PWERM/OPM models, memo archives; input sources; change logs; backtesting analyses conducted historically.
• Governance artifacts:
  • Existing policies, committee charters, process maps, sign-off matrices; independent valuation firm engagement letters and reports; audit PBC lists and prior period tie-outs.
• Fair value disclosures:
  • Financial statement notes for ASC 820; Level 3 roll-forward tables; sensitivity disclosures; ILPA/IPEV packages; regulator correspondence (if any).
• Continuation/secondary processes:
  • Pricing analyses, bid decks, fairness opinions (drafts if available), tender mechanics, GP-led continuation materials; valuation date conventions used.
• Systems and controls:
  • Document management repositories, access logs, version control practices; internal control documentation; evidence retention schedules.

Common data pitfalls included incomplete cap tables and security terms for complex structures, outdated comp sets, missing market data source citations, limited documentation of management forecast changes, sparse backtesting records, inconsistent hierarchy classification rationale, and fragmented PBC artifacts. We established a data dictionary and sourcing hierarchy and reconciled open items before policy finalization.

5) Questions for Client

• What valuation techniques and inputs have generated the most auditor or LP questions historically?
• How should materiality thresholds and approval levels be defined for VRC deliberations and hierarchy transfers?
• Which calibration practices at initial recognition are acceptable; how should subsequent re-calibration be handled after follow-on rounds or structural changes?
• What sensitivity analysis bands are appropriate for significant unobservable inputs (multiples, WACC, volatility, DLOM/DLOC)?
• What coverage and rotation do you expect from independent valuation providers; what is the desired interplay with internal valuations?
• Which elements of continuation/secondary pricing should be reconciled explicitly to quarterly policy (valuation date, methodology, fairness opinion parameters)?
• What evidence retention and control attestations are needed for regulator and LP diligence?
• How should valuation memos be tailored by asset class (control positions, minority growth equity, distressed debt) and fund strategy?
• What close calendar constraints exist (portfolio company reporting lags, audit timelines); what changes are feasible?
• What dashboards and disclosures should be part of board and LP reporting each quarter; what lineage to GL and accounting is required?

6) Interview Guide for Subject Matter Experts

CFO / Valuation Lead

• Where do quarter-end bottlenecks occur; which inputs or assets are consistently late or contested?
• How are methodology and unit of account determined today; where do exceptions arise?
• What has driven prior auditor proposed adjustments; which areas need pre-clearance?

Controller / Fund Finance

• How do you source and archive market data and inputs; where do tie-outs to GL and disclosures break?
• What is the current PBC process; how can it be standardized?
• How are Level 3 roll-forwards and sensitivity disclosures prepared today?

Deal Team Lead / Operating Partner

• What performance metrics are most predictive for your assets; how should they inform valuation models?
• Where do management forecasts diverge from market participant assumptions; how should adjustments be documented?
• What events (customer churn, pricing resets, regulatory changes) require intra-quarter remeasurement considerations?

Independent Valuation Provider

• Which inputs or methods typically drive review notes; how can templates anticipate them?
• What level of documentation speeds your review; where do policy gaps slow sign-off?
• How should rotation and materiality be defined to maximize value?

External Auditor (valuation specialist or core team)

• Which judgments require early alignment (DLOM, WACC components, PWERM vs. OPM selection, hierarchy transfers)?
• What evidence do you expect for calibration and backtesting; how should sensitivity be presented?
• What timing and PBC structure reduces late-stage rework?

General Counsel / Compliance

• Which regulator or LP requests on fair value have emerged; how should documentation respond?
• What conflicts & allocation considerations intersect with valuation choices (e.g., fees, continuation processes)?
• What record retention and access controls should apply?

IT / Data Governance

• What repositories and access controls exist for valuation workpapers; how can versioning be enforced?
• What audit trails are feasible for model changes and input updates?

7) Timeline

We executed a 12–14 week plan tailored to Valuation Policy & Fair Value Governance within Finance.

• Weeks 1–2: Diagnostic & Policy Blueprint
  • Reviewed current memos, models, disclosures, and auditor/independent valuer feedback; drafted policy outline and methodology decision trees; defined hierarchy classification rules and documentation standards.
  • Decision Gate A: Approved policy blueprint, sourcing hierarchy, and data request.
• Weeks 3–4: Calibration & Model Library
  • Built calibration templates; curated model inventory (DCF, GPCM/GTM, PWERM/OPM/Monte Carlo, debt valuation); defined input governance and sensitivity bands; implemented version control.
  • Decision Gate B: Ratified model templates, input sources, and sensitivity standards.
• Weeks 5–6: VRC & Close Calendar
  • Established VRC charter, quorum, and approval thresholds; published quarterly close calendar; designed attestation and sign-off forms; codified segregation of duties.
  • Decision Gate C: Confirmed governance and calendar; aligned stakeholders on roles.
• Weeks 7–8: Memo Templates & Auditor Alignment
  • Finalized memo templates; prepared tie-out deck and standing PBC index; conducted auditor pre-clear sessions on policy interpretations and independent valuer scope.
  • Decision Gate D: Approved templates and PBC process; locked auditor expectations.
• Weeks 9–10: Pilot Quarter & Backtesting
  • Executed a pilot across a subset of assets; ran calibration and memo preparation; held VRC; compiled backtesting analyses; documented issues and remediations.
  • Decision Gate E: Reviewed pilot findings; approved remediation plan and rollout to all assets.
• Weeks 11–12: Controls, Disclosures & Training
  • Finalized control matrix and evidence trail; produced ASC 820 disclosures and internal dashboards; delivered training to preparers/reviewers; launched repository and change-control SOPs.
  • Decision Gate F: Authorized steady-state operations; scheduled quarterly refresh and annual benchmarking.
• Weeks 13–14 (optional): Continuation Integration & Audit Prep
  • Integrated continuation/tender pricing workflows; prepared fairness opinion support pack; conducted audit dry run; updated FAQs and policy addenda.

Critical path items included policy interpretation alignment with auditors/independent valuation providers, model and input governance, calibration/backtesting readiness, committee setup, and documentation controls suitable for regulator and LP diligence.

8) Deliverables

• Valuation Policy & Procedures Manual
  • ASC 820 operationalization (unit of account, exit price, hierarchy classification), methodology selection framework, input sourcing hierarchy, disclosure standards, and exceptions process.
• Calibration & Backtesting Framework
  • Templates and logs for initial and ongoing calibration; backtesting dashboards with attribution to inputs and performance; remediation playbook.
• Model Library & Input Governance Pack
  • Standardized DCF/GPCM/GTM/PWERM/OPM/Monte Carlo templates; WACC and credit spread build models; DLOM/DLOC methodology guide; sensitivity toolkit; model inventory and change logs.
• Valuation Review Committee Charter & Close Calendar
  • RACI, independence standards, quorum and approval thresholds, meeting agendas and minutes templates; quarterly close calendar with milestones and owners.
• Valuation Memo Templates & Evidence Checklist
  • Equity/debt memo formats; source citation checklist; management representation letter templates; calibration and sensitivity sections; hierarchy and unit of account write-ups.
• Audit & Independent Valuer Alignment Toolkit
  • Standing PBC index; tie-out deck; scope and rotation guidelines for independent valuations; pre-clear memos on key judgments.
• Continuation/Secondary Valuation Addendum
  • Policy for GP-led continuation, tender, and strip sale pricing; reconciliation exhibits; fairness support pack templates.
• Controls & Evidence Repository
  • Valuation control matrix; certification and sign-off forms; document repository structure with access controls; retention schedules and versioning SOPs.
• ASC 820/ILPA Disclosure Templates & Dashboards
  • Techniques and inputs, Level 3 roll-forward, sensitivity disclosures; internal dashboards for mark drivers, calibration status, backtesting variance, and VRC issue tracking.
• Training & Playbook
  • Role-based training modules; practical guides for deal teams and preparers; policy refresh cadence; auditor/independent valuer feedback loop process.

9) Industry Insights

• ASC 820 rigor is shifting from “what” to “how”
  • Policies that read well but lack operational procedures fall short in audits and examinations. Model governance, calibration logs, and evidence trails are becoming core expectations.
• Calibration is the anchor for credibility
  • Initial recognition links and ongoing recalibration to observable inputs reduce drift and late-cycle surprises; backtesting closes the loop and informs judgment ranges going forward.
• Option-based and scenario methods are mainstream for complexity
  • PWERM, OPM, and Monte Carlo are expected where capital structures and outcomes are non-linear; auditor comfort improves with standardized templates and transparent assumptions.
• Continuation vehicles require dual-track discipline
  • Reconciling continuation pricing to quarterly policy and preparing fairness-ready materials accelerates processes and tempers re-trade risk.
• DLOM/DLOC require method and market consistency
  • Restricted stock studies, protective put approaches, and empirical models need to be applied consistently with defensible ranges and linked to liquidity timelines.
• Transparency expectations extend beyond the footnotes
  • LPs and consultants increasingly request gross-to-net bridges and Level 3 disclosures aligned to ILPA/IPEV; dashboards that tie to GL and valuation memos streamline diligence.
• Controls mirror public-company disciplines—even when not required
  • Segregation of duties, change-control, and evidence retention reduce audit cycles and examination risk; they also protect institutional memory through team changes.
• What “good” looks like
  • An ASC 820 policy with operational procedures; calibration/backtesting discipline; standardized models and inputs with sensitivity; VRC governance and close calendar; aligned auditor/independent valuer workflows; continuation integration; ICFR-like controls and evidence repository; ASC 820/ILPA disclosures reconciled to GL; and trained teams executing to cadence.
• Near-term watch points
  • Market volatility and interest rate shifts affecting WACC and multiples; increased scrutiny of DLOM/DLOC; GP-led secondaries pricing dispersion; regulator focus on valuation controls and disclosures; and auditor rotation/independence changes. Quarterly benchmarking and policy refresh keep programs current and defensible.

Implications for clients we served included enabling Mega/Large-Cap Private Equity Buyout Firms to harmonize fair value governance across complex platforms; supporting Mid-Market & Lower Mid-Market Private Equity Sponsors to institutionalize ASC 820 procedures that shorten audit cycles; equipping Growth Equity Investors (Private Equity) to scale valuation with lean teams through standardized templates and controls; guiding Private Equity Operating Partners & Value Creation Teams to provide decision-useful performance inputs aligned with market participant assumptions; and providing PE-Owned Portfolio Companies clarity on quarterly data expectations, improving timeliness and consistency of valuation support.